Ayca Dundar

40PUBLICATIONS
234CO-AUTHORS
Predictive and prognostic markersPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Sep 28, 2026
Cardiovascular Risk Triage Schema for Patients With Prostate Cancer Treated With Hormone Therapy.

|Jun 18, 2026
Rucaparib - drug evaluation: a PARP inhibitor for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer.

|Mar 25, 2026
Carboplatin, Cabazitaxel, and Abiraterone in High-Volume Metastatic Castration-Sensitive Prostate Cancer: The CASCARA Phase II Study.

Emmanuel S Antonarakis, Qing Cao, Victoria Catharine

|Mar 12, 2026
Prognostic Significance of Blood-Based Multicancer Detection in Circulating Tumor DNA: Five-Year Outcomes Analysis.

Charles Swanton, Alan Bryce, Allen L Cohn

|Feb 26, 2026
Trial Design and Objectives for Patients With Prostate Cancer: Recommendations From the Prostate Cancer Working Group 4.

Andrew J Armstrong, Michael J Morris, Wassim Abida

|Dec 04, 2025
Additive Clinical Utility of Microsatellite Instability and Tumor Mutational Burden to Predict Immune Checkpoint Inhibitor Effectiveness in Metastatic Castration-Resistant Prostate Cancer.

Nicolas Sayegh, Ryon P Graf, Umang Swami

Pageof 7

Frequent Collaborators

9 joint publications

Emmanuel S Antonarakis

7 joint publications

Oliver Sartor

6 joint publications

Michael Morris

6 joint publications

Rana R Mckay